Capienda Biotech
Carlsbad
About Capienda Biotech
Capienda saves time (1-2 yrs) and cost ($1 Billion) to develop new medicines by opening a key bottleneck in drug discovery. Capienda provides missing results for better small molecule designs: higher quality drugs enter clinical trials. * First high-throughput kinetics system for small molecule drugs. * 48x throughput of Biacore. * Specialist scientists not required. Product is laboratory instrument system + assay chemicals (recurring revenues).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $685.0K
- Funding stage: Seed
- Last round: Grant (Aug 2025)
- Website: capienda.us
- Phone: 619-857-0844
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/capienda-biotech-146116 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.